PNU-22394
| Clinical data | |
|---|---|
| Other names | PNU22394; PNU-22394A; PNU22394A; U-22394A; U22394A |
| Routes of administration | Oral |
| Drug class | Serotonin 5-HT2C receptor agonist; Non-hallucinogenic serotonin 5-HT2A receptor agonist; Serotonin 5-HT2B receptor weak partial agonist or antagonist |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H16N2 |
| Molar mass | 200.285 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
PNU-22394, or PNU-22394A, also known as U-22394A, as well as 6-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole, is a serotonin 5-HT2 receptor agonist of the ibogalog family which was studied as an appetite suppressant and antipsychotic but was never marketed. As an ibogalog, PNU-22394 is a cyclized tryptamine and a simplified ibogaine analogue.